Antimicrobial Susceptibility Testing Market Set for Steady Growth at 6.1% CAGR, Reaching $5.09 Billion by 2027

London, 13-09-2023 - The global Antimicrobial Susceptibility Testing (AST) market is poised for robust growth, with a projected Compound Annual Growth Rate (CAGR) of approximately 6.1% from 2019 to 2027. The market is expected to reach a valuation of $5.09 billion by 2027. AST plays a crucial role in determining the effectiveness of antibiotics against bacteria and fungi responsible for infections. This testing aids healthcare practitioners in selecting the most suitable antibiotics for treatment, essential in the face of rising global infectious disease burdens.

Antimicrobial susceptibility testing assesses the susceptibility of microorganisms to antimicrobial agents. The results guide healthcare providers in making informed treatment decisions, contributing to better patient outcomes.

Key Market Players- https://meticulousblog.org/top-10-companies-in-antimicrobial-susceptibility-testing-market/

Here are the top 10 companies making significant strides in the Antimicrobial Susceptibility Testing (AST) market:

bioMérieux S.A. (Founded 1963, Headquarters: l’Etoile, France)
bioMérieux is a leader in in vitro diagnostics solutions, dedicated to combating infectious diseases and cancers.
Their product range includes culture media, MIC strips, and automated laboratory instruments for conducting antibiotic susceptibility testing.
Danaher Corporation (Founded 1969, Headquarters: Washington, D.C., U.S.)
Danaher operates in the AST market through its diagnostics business segment, offering microbiology systems, identification systems, and AST panels.
Becton, Dickinson and Company (Founded 1906, Headquarters: New Jersey, U.S.)
BD operates in the AST market through its BD Life Sciences business segment, providing products to detect infectious diseases, including diffusion discs and Phoenix systems for automated antimicrobial susceptibility testing.
Bio-Rad Laboratories, Inc. (Founded 1952, Headquarters: California, U.S.)
Bio-Rad operates in the AST market through its clinical diagnostics business segment, offering susceptibility testing disks, plates, and AST media.
Thermo Fisher Scientific Inc. (Founded 2006, Headquarters: Massachusetts, U.S.)
Thermo Fisher provides antimicrobial susceptibility testing products through its microbiology business segment, serving healthcare, clinical, pharmaceutical, industrial, and food safety laboratories.
HiMedia Laboratories Pvt. Ltd. (Founded 1973, Headquarters: Mumbai, India)
HiMedia offers media and antimicrobial susceptibility tests for selecting appropriate antimicrobial agents.
Merlin Diagnostika GmbH (Founded 1990, Headquarters: North Rhine-Westphalia, Germany)
A subsidiary of Bruker Corporation, Merlin Diagnostika provides automated and manual susceptibility testing products under the MICRONAUT brand.
Merck KGaA (Founded 1668, Headquarters: Darmstadt, Germany)
Merck KGaA offers antimicrobial susceptibility testing products in the life science business segment through its subsidiaries Sigma-Aldrich Corporation and Millipore Corporation.
Accelerate Diagnostics, Inc. (Incorporated 1982, Headquarters: Arizona, U.S.)
Accelerate Diagnostics provides solutions for fast diagnosis of serious infections, including the Accelerate Pheno system for identifying and testing pathogen susceptibility.
Alifax S.r.l. (Founded 1988, Headquarters: Polverara, Italy)
Alifax specializes in clinical diagnostic instrumentation, including automated AST systems like SIDECAR, Alfred 60/AST, and HB&L.
Antimicrobial Susceptibility Testing Market's Elite: The Top 10 Companies of 2023- https://meticulousblog.org/top-10-companies-in-antimicrobial-susceptibility-testing-market/

These companies are at the forefront of the AST market, driving innovation and advancements in microbial susceptibility testing.

Market Insights

The AST market's projected growth reflects the increasing global need for susceptibility testing as infectious diseases continue to pose significant challenges. Scientists are actively developing broad-spectrum antibiotics and evaluating microbial susceptibility, further propelling market expansion.

For a comprehensive analysis of each company, including recent financial performance, key products, strategies, partnerships, and acquisitions, refer to Meticulous Research®'s report, "Antimicrobial Susceptibility Testing Market – Global Opportunity Analysis and Industry Forecast (2019-2027)."

For more information and in-depth market insights, please visit www.meticulousresearch.com.

Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research